Cui Qian, Tan Wen, Song Bao, Peng Rou-Jun, Wang Ling, Dorajoo Rajkumar, Ng Kok Pin, Lin Guo-Wang, Au Wing-Yan, Liang Raymond H S, Khor Chiea Chuen, Zhang Qing-Ling, Foo Jia Nee, Li Sheng-Ping, Zhang Fu-Ren, Zhang Xue-Jun, Yu Xue-Qing, Lan Qing, Chanock Stephen, Jia Wei-Hua, Lim Soon Thye, Li Wen-Yu, Rothman Nathaniel, Bei Jin-Xin, Liu Jie, Lin Dongxin, Liu Jian-Jun
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, Guangdong, China.
Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Leukemia. 2025 Mar;39(3):694-702. doi: 10.1038/s41375-024-02503-4. Epub 2024 Dec 20.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy and the most common form of non-Hodgkin lymphoma (NHL) that occurs worldwide. To discover risk factors and pathogenesis of DLBCL, we performed the largest GWAS of DLBCL to date in samples of East Asian ancestry, consisting of 2,888 patients with DLBCL and 12,458 controls. The meta-analysis identified three novel loci, rs2233434 on 6p21.1 (OR = 1.26, P = 1.17 × 10), rs11066015 on 12q24.12 (OR = 1.24, P = 6.57 × 10) and rs6032662 on 20q13.12 (OR = 1.24, P = 5.22 × 10). Fine mapping analysis revealed that the extensive association within the MHC region was driven by two novel HLA alleles, HLA-A02 and HLA-DQB103. Functional annotation, eQTL and colocalization analyses of the susceptibility loci implicated NFKBIE/TCTE1, ALDH2/BRAP and CD40 as candidate disease genes. The pleiotropic effect analysis of the DLBCL loci revealed shared genetic susceptibility between DLBCL and several autoimmune diseases. Our study also suggested genetic heterogeneity between Asian and European populations by identifying ancestry-specific genetic associations. Overall, this study has implicated novel disease genes and molecular mechanism for DLBCL.
弥漫性大B细胞淋巴瘤(DLBCL)是一种侵袭性恶性肿瘤,也是全球最常见的非霍奇金淋巴瘤(NHL)形式。为了发现DLBCL的危险因素和发病机制,我们在东亚血统样本中进行了迄今为止最大规模的DLBCL全基因组关联研究(GWAS),该研究包括2888例DLBCL患者和12458例对照。荟萃分析确定了三个新的基因座,分别是6p21.1上的rs2233434(比值比[OR]=1.26,P=1.17×10)、12q24.12上的rs11066015(OR=1.24,P=6.57×10)和20q13.12上的rs6032662(OR=1.24,P=5.22×10)。精细定位分析表明,MHC区域内的广泛关联是由两个新的HLA等位基因HLA-A02和HLA-DQB103驱动的。对易感基因座的功能注释、表达定量性状基因座(eQTL)和共定位分析表明,NFKBIE/TCTE1、ALDH2/BRAP和CD40是候选疾病基因。DLBCL基因座的多效性效应分析揭示了DLBCL与几种自身免疫性疾病之间存在共同的遗传易感性。我们的研究还通过识别特定血统的遗传关联,提示了亚洲和欧洲人群之间的遗传异质性。总体而言,本研究揭示了DLBCL新的疾病基因和分子机制。